You are here: Industry Insights > HistoIndex

News List

BRIDGING CLINICAL RESEARCH AND CLINICAL CARE WITH AI-AIDING PATHOLOGISTS TOOL PR Newswire
December 09, 2024
The National Institutes of Health (NIH) and a panel of distinguished international liver pathologists showcased how Artificial Intelligence (AI) is revolutionizing the evaluation of liver fibrosis in metabolic dysfunction-associated steatohepatitis (MASH)
HistoIndex's AI-Based Digital Pathology Indicates Concomitant Histological Improvements in Liver Fat and Fibrosis in Nonalcoholic Steatohepatitis (NASH) Patients Treated with Tropifexor Compared with prnasia
June 28, 2021
HistoIndex's Second Harmonic Generation (SHG) stain-free digital pathology platform has shown marked reduction in liver fibrosis (overall, reduction in perisinusoidal fibrosis, as well as regression of fibrous septa) from baseline to end-of-treatment ...
HistoIndex Explores the Clinical Utility of Stain-free AI Digital Pathology Platform in 388 Patients with Triple-Negative Breast Cancer (TNBC) prnasia
January 25, 2021
HistoIndex's stain-free AI digital pathology platform, incorporating Second Harmonic Generation (SHG), holds promise as a quantitative tool in the assessment of morphological and architectural changes in collagen fibers within the tumor-stromal ...
HistoIndex and ILBS Launch Centre of Excellence in India biospectrumasia
August 08, 2019
The Center of Excellence aims to enhance Nonalcoholic Steatohepatitis (NASH) advanced Diagnostics and Clinical Research in New Delhi with HistoIndex's AI-based Second Harmonic Generation (SHG) digital pathology platform
Histoindex receives Frost & Sullivan 2017 Asia- Pacific best Practices award biospectrumasia
October 09, 2017
The award is a testament of the achievements by HistoIndex and the impact of its proprietary technologies on aiding clinical diagnosis and the development of NASH therapeutics.